WHO's SAGE recommends use of Sanofi Pasteur's dengue vaccine in endemic countries
It also recognised strong public health benefit to be gained by introduction of Dengvaxia, dengue vaccine15-04-2016
15-04-2016
Public dengue immunisation program launched in Philippines
1 million students from 6,000 public schools to begin dengue vaccinations this year The first public dengue immunisation programme has started in the Philippines. Reportedly, the public immunisation programme will begin vaccinating one million students from 6,000 public schools this year in three highly dengue-endemic regions of the country. Dengvaxia, Sanofi Pasteur's tetravalent dengue vaccine, []05-04-2016
Q1 results on April 29, 2016
Sanofi India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on April 29, 2016, for approving the unaudited financial results for the quarter ended March 31, 2016, which is the first quarter of the Companys financial year (Q1).04-04-2016
AGM on April 29, 2016
Sanofi India Ltd has informed BSE that the 60th Annual General Meeting (AGM) of the Company will be held on April 29, 2016.29-03-2016
Fixes Book Closure for Dividends & AGM
Sanofi India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from April 19, 2016 to April 29, 2016 (both days inclusive) for the purpose of Payment of Dividends & Annual General Meeting (AGM) of the Company to be held on April 29, 2016.The said proposed Final Dividend & Two Special One-time dividends will be paid on May 09, 2016.29-03-2016
Vijay Mallya quits as chairman Sanofi India
Mallya had first joined in December 1973 as director of Sanofi India Ltd (SIL), then known as Hoechst Pharmaceuticals Ltd. He functioned as the board chairman since December 1983.25-03-2016
Vijay Mallya says will retire from chairmanship of Sanofi India
Sanofi India will seek approval to appoint Aditya Narayan, Usha Thorat as independent directors for a term of five years each from 30 April 201623-03-2016
Dr. Vijay Mallya decides not to seek re-election as Director of Sanofi India Limiteds Board at ensuing AGM
Sanofi India Ltd has informed BSE regarding a Press Release dated March 23, 2016 titled "Dr. Vijay Mallya decides not to seek re-election as Director of Sanofi India Limiteds Board at ensuing AGM".23-03-2016
Outcome of Board Meeting
Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 23, 2016, has recommended to the shareholders that resolutions be passed at the ensuing Annual General Meeting for electing Mr. Aditya Narayan and Ms. Usha Thorat as Independent Directors for a term of five years each from April 30, 2016.23-03-2016
Change in Directorate
Sanofi India Ltd has informed BSE that Dr. Vijay Mallya, Chairman of Board of Directors of the Company, has informed the Board that he would not seek re-election as a Director at the ensuing Annual General Meeting (AGM).A copy of the letter addressed to the Board by Dr Vijay Mallya is enclosed.Consequently, Dr Mallya will cease to be a Director and Chairman of the Board of Directors of the Company at the conclusion of the Companys Annual General Meeting....23-03-2016